Dopamine adverse event reports that FDA received

Name: Reaction terms in FDA adverse event reports that name Dopamine
Creator: Reported Reactions
License: https://creativecommons.org/publicdomain/zero/1.0/

Name type: Generic name
Class: Catecholamine

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Drug reports received through 30 Jun 2026. Device reports have a separate cutoff, 30 Sep 2026. Why a report count is not a rate.

Reports on file

From November 2004 to June 2026, FDA received 947 adverse event reports that name Dopamine. In these reports the drug is a suspect or interacting product.

In the same period, 2,086 further reports name it only as a concomitant medicine. The counts on this page do not include these reports.

FDA received 71 reports in the 12 months to June 2026 and 83 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 71 (under 0.1%) name Dopamine. Reports from consumers or other non-health professionals were 7.2% of the reports that name Dopamine and 45.8% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.

There are many instances of duplicative reports and some reports do not contain all the necessary information.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Suspect product

FDA records each drug in a report as suspect, concomitant or interacting. This page counts the reports in which Dopamine is suspect or interacting. FDA says:

Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Since the last update

FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The information in these reports cannot be used to estimate the incidence (occurrence rates) of the events reported.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

The latest update of the FDA data, recorded on 28 Oct 2026, changed no count of this page.

In April to June 2026, FDA received 12 reports that name Dopamine.
In January to March 2026, FDA received 17.
In April to June 2025, FDA received 28.

April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.

All updates Feed of updates (RSS)

Reaction lookup

These are the reaction terms that the reports record, with the number of reports for each term. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 135 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for 906 of the 947 reports (95.7%).

The reports of the other years are not in the counts.

So a count in the table can be lower than the count of FDA.

Find a reaction term

The table shows the first 50 of 135 terms.

Reaction terms in the reports that name Dopamine, most reports first
Reaction term (MedDRA) and plain meaning	Reports	Share of the 947 reports
Drug ineffectivethe medicine did not work as expected	408	43.1%
Hypotensionlow blood pressure	112	11.8%
Off label useused for a purpose or in a way not on the label	75	7.9%
Toxicity to various agentspoisoning or toxic effect of one or more substances	71	7.5%
Acute kidney injurysudden loss of kidney function	56	5.9%
Cardiac arrestthe heart stopped	55	5.8%
Condition aggravatedthe condition being treated got worse	52	5.5%
Therapy non-responderthe treatment did not work	51	5.4%
Drug interactionan interaction between medicines	48	5.1%
Intentional overdosea deliberate overdose	45	4.8%
Metabolic acidosistoo much acid in the body fluids	42	4.4%
Bradycardiaslow heart rate	38	4%
Overdosea dose above the recommended amount	36	3.8%
Cardiogenic shockshock from the heart failing to pump	35	3.7%
Multiple organ dysfunction syndromeseveral organs failing	32	3.4%
Seizurea fit or convulsion	32	3.4%
Drug ineffective for unapproved indication	30	3.2%
Coma	29	3.1%
Foetal exposure during pregnancythe unborn baby was exposed to the medicine	28	3%
Shockshock, a collapse of the circulation	28	3%
Deaththe patient died; cause not stated by this term	26	2.7%
Vomitingbeing sick	25	2.6%
Cardiac failureheart failure	23	2.4%
Diarrhoealoose or frequent stools	22	2.3%
Maternal exposure during pregnancythe mother took the medicine during pregnancy	22	2.3%
Tachycardiafast heart rate	22	2.3%
Pulmonary oedemafluid in the lungs	21	2.2%
Haemodynamic instability	20	2.1%
Nauseafeeling sick	19	2%
Exposure during pregnancythe medicine was taken during pregnancy	18	1.9%
Renal impairmentreduced kidney function	18	1.9%
Premature babya baby born early	17	1.8%
Loss of consciousnesspassing out	16	1.7%
Suicide attempta suicide attempt	16	1.7%
Completed suicidedeath by suicide	15	1.6%
Falla fall	15	1.6%
Fatiguetiredness	15	1.6%
Hypertensionhigh blood pressure	15	1.6%
Ventricular tachycardiaa fast rhythm from the lower heart chambers	15	1.6%
General physical health deteriorationgeneral decline in health	14	1.5%
Anuria	13	1.4%
Encephalopathy	13	1.4%
Epistaxisnosebleed	13	1.4%
Foetal death	13	1.4%
Gait disturbancedifficulty walking	13	1.4%
Respiratory depressionslow or shallow breathing	13	1.4%
Anal haemorrhage	12	1.3%
Blood glucose increasedraised blood sugar reading	12	1.3%
Dementia	12	1.3%
Electrocardiogram QT prolongeda QT prolongation on the ECG	12	1.3%

Download all 135 terms of Dopamine (CSV)

The counts add to more than 947 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The CSV file has the same rows and the same limits. Its last row is a note that says so.

MedDRA term

The person who codes a report selects the preferred term that agrees best with the description of the reporter. The words under a term are the plain meaning that this site gives.

Not the label

The FDA-approved label of a product lists its adverse reactions. See the official pages at the end of this page.

Same ingredient, other names

Reporters write a brand name or a generic name. Each name has its own page and its own count.

Names of Dopamine with a page, in the order generic names, brand names, names as reported
Name	Name type	Reports
Dopamine (this page)	Generic name	947
Dopamine hydrochloride	Generic name	422

Sum of the separately reported names: 1,369. A report that names two of these names is in the sum two times. The sum is not the number of reports for the ingredient.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Outcomes by year

The table gives the outcomes that the reporters gave, in the terms of FDA.

Outcomes in the reports that name Dopamine, by the year of the openFDA file that holds the report

The table continues to the right.

Year of the openFDA file	Reports	Serious	Death	Life-threatening	Hospitalization (initial or prolonged)	Disability or Permanent Damage	Congenital Anomaly/Birth Defect	Other Serious (Important Medical Events)	Not serious
2004	2	2	2	1	0	0	0	2	0
2005	6	3	0	0	1	0	0	2	3
2006	7	5	1	0	2	1	0	2	2
2007	0	0	0	0	0	0	0	0	0
2008	0	0	0	0	0	0	0	0	0
2009	1	1	0	1	0	0	0	1	0
2010	3	2	0	1	0	0	0	2	1
2011	5	5	2	0	1	0	0	2	0
2012	6	6	3	2	3	0	0	3	0
2013	11	11	1	6	2	1	0	7	0
2014	12	12	6	2	5	0	0	6	0
2015	16	14	5	1	3	1	0	11	2
2016	36	34	8	4	18	4	0	21	2
2017	49	48	18	16	14	2	0	32	1
2018	63	62	19	16	30	0	0	48	1
2019	86	69	20	27	52	0	0	33	17
2020	92	90	27	22	68	0	2	49	2
2021	150	148	39	49	107	5	0	76	2
2022	85	83	29	37	61	0	0	31	2
2023	94	94	50	32	56	3	4	44	0
2024	89	87	26	21	59	0	0	48	2
2025	95	93	37	39	61	1	1	50	2
2026	39	39	11	19	32	0	0	24	0

An outcome in a report is not proof that the drug was the cause. The reporter gives the outcome, and FDA does not verify it. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

The six headings with the names of FDA are the outcome terms of FDA. A report can have more than one outcome. The columns Serious and Not serious are the two values of the openFDA field serious. For the value serious, openFDA gives this description:

The adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition
Source: openFDA, Drug adverse event fields (YAML reference). The site read the page on 2 Oct 2026.

The year is the year of the openFDA file that holds the latest version of the report. It is not always the year in which FDA first received the report. The chart of the next section uses the year of first receipt. The latest year is not complete.

Reports by year and month

Reports that name Dopamine, by the year in which FDA received them

The column of 2026 has an outline, because the year is not complete. It has the reports that FDA received through June 2026 only.

Show the figures of the chart as a table

Reports that name Dopamine, by the year in which FDA received them
Year	Reports
2004	2
2005	6
2006	8
2009	1
2010	3
2011	7
2012	5
2013	10
2014	12
2015	18
2016	39
2017	56
2018	70
2019	93
2020	103
2021	142
2022	83
2023	89
2024	86
2025	85
2026	29

Reports that name Dopamine, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Why a count moves

A count moves for many reasons. The guide gives FDA's words about them.

Patients and reporters

Age of the patient in the reports that name Dopamine
Age	Reports	Share
Under 2	78	8.2%
2 to 11	49	5.2%
12 to 17	35	3.7%
18 to 44	200	21.1%
45 to 64	151	15.9%
65 to 74	100	10.6%
75 and over	68	7.2%
Age not given	266	28.1%

Sex of the patient in the reports that name Dopamine
Sex	Reports	Share
Female	403	42.6%
Male	403	42.6%
Unknown or not given	141	14.9%

Type of reporter in the reports that name Dopamine
Reporter	Reports	Share
Physician	283	29.9%
Pharmacist	22	2.3%
Other health professional	552	58.3%
Lawyer	2	0.2%
Consumer or non-health professional	68	7.2%
Not given	20	2.1%

Age and sex are as the report gives them. The reporter is the primary source in the report. 44.9% of the reports give the United States as the country.

Reason for use

Reason for use (indication) that the reports of Dopamine record
Indication as recorded (MedDRA)	Reports	Share
Hypotension	143	15.1%
Shock	37	3.9%
Cardiogenic shock	29	3.1%
Septic shock	25	2.6%
Cardiac arrest	22	2.3%
Capillary leak syndrome	16	1.7%

The reporter fills in the indication, and the field is often empty. Each share is of all 947 reports.

Drugs in the same reports

Other drugs that the reports of Dopamine name, in any role, in order of name
Drug	Reports that name the two
Dobutamine	173
Epinephrine	306
Furosemide	144
Hydrocortisone	101
Meropenem	78
Norepinephrine	367
Phenylephrine	82
Sodium bicarbonate	72
Vancomycin	105
Vasopressin	156

The table has the 10 drug names that these reports name most. Two names in one report says only that the report recorded the two. It says nothing about the part of a product in the event.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pages near this one

Dopamine hydrochloride same ingredient
Auvi-q same class
Adrenalin(r) same class
Epinephrine same class
Epinephrine hydrochloride same class
Donepezil/Donepezil Hydrochloride next in the A to Z list
Donepezil hydrochloride next in the A to Z list
Doptelet next in the A to Z list
Donepezil hcl next in the A to Z list
Dormicum next in the A to Z list
Donepezil next in the A to Z list
Doryx next in the A to Z list

These links are for navigation. No count selected them. The class page lists each drug of the class.

Official pages

DailyMed labels for DopamineThe labels (prescribing information) that have this name, at the National Library of Medicine.
MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Dopamine: adverse event reports that FDA received. https://reportedreactions.com/drug/dopamine/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

A report is in the count when it names Dopamine as a suspect or interacting product. The 2,086 reports that name it only as a concomitant medicine are not in the count. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Do these reports show that Dopamine was responsible for the reactions?

No. FDA says:

For any given report, there is no certainty that a suspected drug caused the event.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

A reaction can relate to the condition that the drug treats, to other medicines, or to something else.

Is this the list of reactions on the label of Dopamine?

No. It is a count of what people reported to FDA: 947 reports from November 2004 to June 2026. The FDA-approved label of a product lists its adverse reactions. The official pages at the end of this page link to the labels.

Who sent these reports?

Other health professional (58.3%), physician (29.9%) and consumer or non-health professional (7.2%). These are the types of reporter for the reports that name this drug.

If a manufacturer receives an adverse event report, it is normally required to send the report to FDA.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.

To the top of the page